Stay updated on CPX-351 and Quizartinib in AML Clinical Trial
Sign up to get notified when there's something new on the CPX-351 and Quizartinib in AML Clinical Trial page.

Latest updates to the CPX-351 and Quizartinib in AML Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded Revision: v3.4.2 to the record history; removed the government-funding/operating-status notice and the previous Revision: v3.4.1 entry.SummaryDifference0.7%

- Check20 days agoChange DetectedAdded a government funding/operating-status notice and updated the site release to Revision: v3.4.1, replacing the previous Revision: v3.4.0.SummaryDifference0.7%

- Check28 days agoChange DetectedThe Record History page UI includes a glossary toggle and color-coded explanations for additions and deletions, plus updated revision notes (e.g., Revision: v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check42 days agoChange DetectedA new revision entry (v3.3.4) was added and an earlier revision (v3.3.3) removed in the study record history; this is a minor/versioning update with no impact on trial data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedA new 2025-12-17 entry adds a Study Status update (revision v3.3.3) to the Record History, and a prior 2025-10-31 entry removed the HHS Vulnerability Disclosure link (revision v3.3.2).SummaryDifference0.5%

- Check91 days agoChange DetectedA new revision entry, v3.3.2, was added to the history. The older revision v3.2.0 was removed from the list.SummaryDifference0.1%

Stay in the know with updates to CPX-351 and Quizartinib in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CPX-351 and Quizartinib in AML Clinical Trial page.